The American Cancer Society projects around 333,830 new prostate cancer cases, 84,530 new bladder cancer cases, and 80,450 new kidney cancer cases in the United States in 2026. While these figures are alarming, the general outlook has improved. Survival rates have climbed across most urological cancers due to earlier detection, targeted therapies, and modern immunotherapy. For a recently diagnosed patient or a loved one in treatment, knowing how the urinary system works, how each cancer type behaves, and what treatments are available may replace uncertainty and provide a sense of control.
How Does the Urinary System Work?
The urinary system filters blood, removes waste, and produces urine. It contains the kidneys, ureters, bladder, and urethra. The adrenal glands are atop each kidney and produce hormones that regulate metabolism, blood pressure, and the body’s stress response. Adrenal cancer also falls under urology, as urologic surgeons perform adrenalectomies, and the glands share blood supply and surgical access with the kidneys. Genitourinary cancers affecting male reproductive organs (prostate, testicles, and penis) are also under urologic care.
What Counts as Urological Cancer?
Urological cancer develops in any organ of the urinary tract or the male reproductive system. The most common types involve the prostate, bladder, and kidneys. Rarer types affect the testicles, penis, urethra, ureters, and adrenal glands. Each cancer type has its own pathology, behavior, risk factors, and treatment protocol.
What Are the Most Common Urological Cancers?
The three most prevalent types are:
Prostate Cancer
The prostate is a walnut-sized gland beneath the bladder and around the urethra. It produces fluid for semen. Prostate cancer develops when cells in this gland multiply out of control and form tumors.
About 1 in 8 men receive a prostate cancer diagnosis during their lifetime. The five-year relative survival rate exceeds 99% for localized disease. In its early stages, prostate cancer produces few or no symptoms. As tumors enlarge, patients may experience difficulty urinating, a weak urine stream, blood in urine or semen, and pelvic discomfort.
New Hope Unlimited’s alternative treatments for prostate cancer employ non-invasive protocols that reverse symptoms and address the tumor’s underlying genetics.
Bladder Cancer
The bladder stores urine before it exits the body. Bladder cancer develops when urothelial cells, which line the inside of the bladder, undergo genetic changes that trigger uncontrolled growth.
The American Cancer Society estimates 64,730 new bladder cancer cases in men and 19,800 in women for 2026. More than 90% of cases in North America involve urothelial (transitional cell) carcinoma. Smoking is the largest preventable risk factor and triples bladder cancer risk.
Visible blood in the urine is the most common warning sign. Painful urination, frequent urges, and lower back pain may also occur. To understand how a holistic approach to this disease and its symptoms works, visit our bladder cancer treatment options and Bladder Cancer Awareness Month pages.
Kidney Cancer (Renal Cell Carcinoma)
The two kidneys are on either side of the spine, beneath the rib cage. They’re responsible for filtering waste from the blood and producing urine. About 90% of malignant growths are renal cell carcinoma (RCC). Less common subtypes include transitional cell carcinoma of the renal pelvis, Wilms tumor in children, and renal sarcoma.
Kidney cancer is a silent disease with few perceptible symptoms in its early stages. As tumors grow, patients may notice blood in the urine, a palpable abdominal mass, flank pain, unintended weight loss, and fatigue. Smoking, obesity, and high blood pressure raise kidney cancer risk. Our alternative treatments for kidney cancer describe how holistic and conventional approaches may work against it.
What Are Rare Urological Cancers?
The urological field encompasses several rare and highly specialized malignancies, including:
Testicular Cancer
Testicular cancer accounts for about 1% of all male malignancies, yet it is the most diagnosed cancer in men ages 15 to 44. Doctors group germ cell tumors into seminomas (slow-growing, treatable) and nonseminomas (fast-growing tumor types like embryonal carcinoma, choriocarcinoma, yolk sac tumors, and teratomas).
Outcomes for testicular cancer are excellent. The five-year survival rate exceeds 95% across all stages and approaches 99% for localized disease. Common signs include a painless lump in the testicle, heaviness in the scrotum, dull lower abdominal pain, and breast tissue enlargement due to hormonal changes.
Our advanced testicular cancer treatment options entail patient-tailored protocols for common and aggressive subtypes.
Penile Cancer
Penile cancer affects fewer than 1 in 100,000 men in the United States each year, and the risk in uncircumcised men is about 1 in 600.
Over 95% of penile cancers are squamous cell carcinomas. Other forms include basal cell carcinoma, melanoma, and sarcoma. Risk factors include chronic inflammation, phimosis, HPV infection, smoking, and poor genital hygiene. Early signs include an unhealing sore, growth, or rash on the penis, along with foul-smelling discharge or bleeding.
Adrenal Cancer
The adrenal glands produce hormones that regulate blood pressure, metabolism, immune response, and the body’s stress reaction. Adrenocortical carcinoma is extremely rare, with only 200 to 500 patients in the United States receiving a diagnosis each year. Many adrenal growths are benign adenomas that may still secrete excess hormones. A thorough examination is necessary to distinguish the two.
Symptoms vary based on whether the tumor secretes hormones. Hormone-producing tumors may cause Cushing-like peculiarities (weight gain, facial rounding, easy bruising), high blood pressure, muscle weakness, and irregular menstrual cycles. Non-functioning tumors may cause abdominal pain, fullness, or a palpable mass.
Primary Urethral and Ureteral Cancers
These cancers are rare. Urethral cancer develops in the tube that transports urine out of the body, while ureteral cancer forms in the muscular tubes that connect the kidneys to the bladder. Most tumors are urothelial carcinomas, similar in cell origin to bladder cancer.
Visible blood in the urine is the earliest and most frequent symptom. Older adults with a history of bladder cancer have a higher risk of ureteral cancer.
What Symptoms Should Push You to See a Doctor?
Many urological cancers cause subtle or no symptoms in the early stages. Watch for the following red flags:
- Blood in the urine, whether visible or found through a urinalysis
- Pain or burning during urination
- A lump or mass in the testicle, scrotum, abdomen, or pelvis
- Persistent lower back or flank pain
- Unintended weight loss and fatigue
- Difficulty urinating, weak stream, or frequent urges
- An unhealing sore, growth, or color change on the penis
- Pelvic discomfort that lingers
Early detection improves survival rates across all urological cancer types. Screening guidelines vary by age and risk. A primary care doctor can advise when to begin prostate-specific antigen (PSA) testing, urinalysis, or imaging studies.
How New Hope Unlimited Approaches Urological Cancer Care
New Hope Unlimited combines evidence-based conventional therapies with precision oncology and immunotherapy protocols that match each patient’s tumor genetics. Because each urological or genitourinary cancer behaves differently, treatments at New Hope Medical Center adapt to the tumor type, mutation pattern, stage, and grade.
In addition, our patients benefit from nutritional guidance, hyperbaric oxygen therapy, and supportive care strategies that address the physical and emotional sides of cancer. To begin a personalized evaluation, schedule a consultation.
FAQs About Urological Cancers
What is the most common urological cancer?
Prostate cancer is the most diagnosed urological cancer in men. Bladder cancer is the second most common.
At what age should men begin prostate cancer screening?
Most guidelines recommend PSA testing at age 50, or between 40 and 45 for men at higher risk due to family history or ethnicity.
Are urological cancers hereditary?
Some are. Mutations in genes like VHL (kidney cancer), BRCA2 (prostate cancer), and Lynch syndrome (urothelial cancers) increase a person’s risk. Most cases, however, develop from acquired mutations during a person’s lifetime.
Is blood in the urine always a sign of cancer?
No. Hematuria is more commonly a result of urinary tract infections, kidney stones, certain medications, or vigorous exercise. A urologist should still evaluate every case to rule out malignancy.
Can a person live with one kidney after cancer surgery?
Yes. One healthy kidney can do the work of two. Many patients live full, active lives after a partial or complete nephrectomy.
Does smoking cause bladder cancer?
Yes. Smokers have three to four times the bladder cancer risk of nonsmokers. Quitting reduces risk over time, though former smokers retain elevated risk for years.
What is the difference between an adrenal adenoma and adrenal cancer?
An adrenal adenoma is a benign growth that does not spread, although it may still produce excess hormones. Adrenocortical carcinoma is malignant and can spread to other organs.
What are the treatments for urological cancers?
Conventional treatment includes surgery, high-dose chemotherapy, radiation, and hormone therapy. Fortunately, precision oncology has emerged, and more doctors are incorporating it into treatment plans. For example, immunotherapy drugs like checkpoint inhibitors now treat advanced bladder and kidney cancers, while targeted therapy attacks the genetic mutations behind tumor growth. For patients with advanced disease, combination protocols often yield the best results.
